Ajovy
Chemical Name | fremanezumab-vfrm |
Dosage Form | Injection (subcutaneously; 225 mg) |
Drug Class | Monoclonal antibodies |
System | Nervous |
Company | Teva Pharmaceuticals USA, Inc. |
Approval Year | 2018 |
Indication
- To prevent migraines in adults.
Chemical Name | fremanezumab-vfrm |
Dosage Form | Injection (subcutaneously; 225 mg) |
Drug Class | Monoclonal antibodies |
System | Nervous |
Company | Teva Pharmaceuticals USA, Inc. |
Approval Year | 2018 |